GlassScriptPhysician profile
Vincent Honrubia
NPI 1487658035
$20,575.48
in general payments reported to CMS, 2019-2025
15 companies · $2,407 in 2025
The $2,407 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,822 · 2020: $2,407 · 2021: $658 · 2022: $7,801 · 2023: $2,142 · 2024: $2,339 · 2025: $2,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,842 · Travel and Lodging: $1,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,841.53 |
| Travel and Lodging | $1,046.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,309.43 | 2022-2025 | Nuvent, Propel, Stealthstation S8 Platform |
| Optinose US, INC. | $5,003.39 | 2020-2025 | |
| Acclarent, INC | $3,704.98 | 2019-2023 | Relieva Spinplus, Trudi Nav Cable, Acclarent Aera |
| Medtronic USA, INC. | $2,403.92 | 2019-2020 | |
| Aerin Medical INC. | $1,173.48 | 2022-2025 | |
| Integra Lifesciences Corporation | $947.52 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Regeneron Healthcare Solutions, INC. | $670.49 | 2020-2025 | Dupixent |
| Glaxosmithkline, LLC. | $494.75 | 2021-2025 | Nucala |
| Olympus America INC. | $457.51 | 2020-2025 | Olympus, Olympus |
| Genzyme Corporation | $273.61 | 2019-2025 | |
| Stryker Corporation | $42.29 | 2022 | |
| Paratek Pharmaceuticals, INC. | $35.20 | 2025 | Xhance |
| Baxter Healthcare | $30.67 | 2020 | |
| Phathom Pharmaceuticals, INC. | $16.33 | 2024 | Voquezna |
| Arbor Pharmaceuticals, INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Honrubia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.